ORAMED PHARMACEUTICALS INC.
Company Stats
- Market Cap
- $167.6M
- Nov 12, 2026 close
- Last Close
- $4.03
- Nov 12, 2026
- Shares Outstanding
- 41.6M
- Free Float
- 64.7%
Income Statement
- Revenue
- $2.0M
- Operating Income
- -$15.1M
- Net Income
- $64.0M
- EBITDA
- -$15.0M
- Revenue Growth, 3Y
- -9.6%
Cash Flow
- Free Cash Flow
- -$9.2M
- FCF Yield
- -5.5%
- Owner FCF Yield
- -9.0%
Balance Sheet
- Cash & Equivalents
- $45.9M
Returns & Capital
- Share Repurchases
- $4.7M
- SBC, 3Y Avg
- $4.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.0M | -$9.2M | -457.7% |
| FY2024 | — | -$8.4M | — |
| FY2023 | $1.3M | -$10.5M | -787.2% |
| FY2022 | $2.7M | -$28.4M | -1051.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at the latest close. Ratios are our calculations from reported figures.